Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Autumn D Zuckerman

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Journal of Managed Care & Specialty Pharmacy|February 6, 2025
Getting to specialty treatment in dermatologic inflammatory conditions: Treatment requirements and patient journeyMatthew G Bowles, Autumn D Zuckerman, Josh DeClercq, et al.
Currents in Pharmacy Teaching & Learning|June 23, 2020
Evaluation of human immunodeficiency virus curricular content in schools of pharmacy in the United StatesR Chris Rathbun, Spencer H Durham, Kevin C Farmer, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 11, 2021
Development, implementation, and evaluation of a health outcomes and research program at an integrated health-system specialty pharmacyAutumn D Zuckerman, Nisha B Shah, Megan E Peter, et al.
Journal of Huntington'S Disease|March 24, 2025
Deutetrabenazine treatment outcomes with doses above U.S. Food and Drug Administration maximum approved doses in Huntington's disease chorea: A dual-site analysisKayla Dodson, Sabrina Livezey, Brittany Denson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2026
Clinical and economic benefits of pharmacist interventions in a non-multiple sclerosis neurology clinicKayla Johnson, Morteza Kaveh, Sabrina Livezey, et al.
Multiple Sclerosis and Related Disorders|May 24, 2022
A cross-sectional analysis of persistence to disease-modifying therapies in treatment naïve and experienced patients with relapsing multiple sclerosis at a health-system specialty pharmacyMiranda Z Kozlicki, Brandon Markley, Nisha B Shah, et al.
Open Forum Infectious Diseases|November 22, 2021
Crushing and Splitting Direct-Acting Antivirals for Hepatitis C Virus Treatment: A Case Series and Literature ReviewKristen Whelchel, Autumn D Zuckerman, David E Koren, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 7, 2025
Putting patients first: Frontline insights on designing and administering manufacturer patient financial support programsAutumn D Zuckerman, Chelsea P Renfro, Danielle Bryan, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 8, 2022
Prescription cannabidiol for seizure disorder management: Initial drug-drug interaction management by specialty pharmacistsHolly Dial, Wendi Owens, Josh DeClercq, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 17, 2019
Development of quality measures for use of self-injectable biologic therapy in inflammatory bowel disease: An integrated specialty pharmacy initiativeNisha B Shah, Jacob A Jolly, Sara N Horst, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Journal of Managed Care & Specialty Pharmacy|February 6, 2025
Getting to specialty treatment in dermatologic inflammatory conditions: Treatment requirements and patient journeyMatthew G Bowles, Autumn D Zuckerman, Josh DeClercq, et al.
Currents in Pharmacy Teaching & Learning|June 23, 2020
Evaluation of human immunodeficiency virus curricular content in schools of pharmacy in the United StatesR Chris Rathbun, Spencer H Durham, Kevin C Farmer, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 11, 2021
Development, implementation, and evaluation of a health outcomes and research program at an integrated health-system specialty pharmacyAutumn D Zuckerman, Nisha B Shah, Megan E Peter, et al.
Journal of Huntington'S Disease|March 24, 2025
Deutetrabenazine treatment outcomes with doses above U.S. Food and Drug Administration maximum approved doses in Huntington's disease chorea: A dual-site analysisKayla Dodson, Sabrina Livezey, Brittany Denson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2026
Clinical and economic benefits of pharmacist interventions in a non-multiple sclerosis neurology clinicKayla Johnson, Morteza Kaveh, Sabrina Livezey, et al.
Multiple Sclerosis and Related Disorders|May 24, 2022
A cross-sectional analysis of persistence to disease-modifying therapies in treatment naïve and experienced patients with relapsing multiple sclerosis at a health-system specialty pharmacyMiranda Z Kozlicki, Brandon Markley, Nisha B Shah, et al.
Open Forum Infectious Diseases|November 22, 2021
Crushing and Splitting Direct-Acting Antivirals for Hepatitis C Virus Treatment: A Case Series and Literature ReviewKristen Whelchel, Autumn D Zuckerman, David E Koren, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 7, 2025
Putting patients first: Frontline insights on designing and administering manufacturer patient financial support programsAutumn D Zuckerman, Chelsea P Renfro, Danielle Bryan, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 8, 2022
Prescription cannabidiol for seizure disorder management: Initial drug-drug interaction management by specialty pharmacistsHolly Dial, Wendi Owens, Josh DeClercq, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 17, 2019
Development of quality measures for use of self-injectable biologic therapy in inflammatory bowel disease: An integrated specialty pharmacy initiativeNisha B Shah, Jacob A Jolly, Sara N Horst, et al.
Pageof 8